POC (照護現場) 膽固醇檢驗的全球市場
POC (Point of Care) Cholesterol Testing Market
|出版日期||內容資訊||英文 37 Pages
|POC (照護現場) 膽固醇檢驗的全球市場 POC (Point of Care) Cholesterol Testing Market|
|出版日期: 2016年01月26日||內容資訊: 英文 37 Pages||
有照護現場 (POC) 檢驗是在患者所在的地方，以及在其附近所施行的診斷檢驗，除了由實驗室人員，還有醫生和護士、藥劑師，或是也有患者自己進行。POC檢驗的優點之一，是可即時知道檢驗結果，迅速進行患者治療的判斷。
本報告提供全球POC (照護現場) 膽固醇檢驗市場相關調查，POC檢驗概要，市場趨勢與至2020年的成長預測，及主要加入企業簡介彙整。
Point of care (POC) tests - diagnostic tests that are performed at or near the site where the patient is located - may be performed by laboratory personnel, but often are performed by non-laboratory personnel such as physicians, nurses, assistants in medical offices, emergency medical technicians (EMTs), medics, pharmacists, and the patients themselves (self-testing). The menu for POC testing includes cholesterol testing. Point of Care (POC) Cholesterol Testing Market analyzes the market for this segment of POC testing.
The report examines the following components of the POC cholesterol market:
One of the key benefits and market drivers for the point of care (POC) testing market is the ability to have rapid results that can be used immediately for patient treatment decisions.
The professional sector is made up of tests used in hospitals, physician offices and clinics. In the core lab, cholesterol testing has gained importance, driven by growing awareness about the risks of heart attack and increasing realization among individuals to control their cholesterol levels. Overall growth in testing volume is driven by factors such as aging population and growing number of people at risk of cardiovascular disease including those with hypertension, diabetes mellitus, and abdominal obesity.
Industry professionals had anticipated that patient self-testing would grow because of rising consumer expectations, technological innovations, and the surge of consumer activism in healthcare. Further pharmacies, retail outlets and the physician office are establishing their position for patient wellness screening. Tests for UTIs, H. pylori, cholesterol PSA, TSH, drugs of abuse and others are readily available in all developed countries. However, these have not caught the imagination of consumers. One of the major issues is that of test interpretation, not so much of the actual result but what the result implies.
Cholesterol testing as an aid to diagnosis of cardiovascular disease and diabetes is discussed, as well as how cholesterol testing may be used in conjunction with the measurement of cardiac biomarkers.
The top and/or innovative competitors discussed within Corporate Profiles are: